Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Danièle Debruyne"'
Publikováno v:
Journal of Pharmacological Sciences, Vol 110, Iss 1, Pp 36-46 (2009)
Abstract.: In this study, we compared the effects of five short-, medium-, or long-acting benzodiazepine-receptor agonists (BZDs) [alprazolam (APZ), clonazepam (CLZ), flunitrazepam (FLZ), loprazolam (LPZ), zolpidem (ZLP)], at two distinct doses, 0.2
Externí odkaz:
https://doaj.org/article/c92ff350969d441f812084d89a68dfa3
Publikováno v:
Case Reports in Cardiology, Vol 2015 (2015)
Externí odkaz:
https://doaj.org/article/371c413c626d42ee9ac78a0930d75f54
Autor:
Laure Peyro-Saint-Paul, Clémence Bechade, Alexandre Cesbron, Danièle Debruyne, Marie Brionne, Sylvie Brucato, Mélanie Hanoy, Audrey Dumont, Anais R Briant, Jean-Jacques Parienti, Thierry Lobbedez, Maxence Ficheux
Publikováno v:
Nephrology Dialysis Transplantation.
Autor:
Amélie Daveluy, Leila Chaouachi, Reynald Le Boisselier, Hélène Peyrière, Caroline Victorri-Vigneau, Frédéric Libert, Joëlle Micallef, Cécile Chevallier, Sylvie Deheul, Maryse Lapeyre-Mestre, Pierre Gillet, Danièle Debruyne, Michel Mallaret, Marie-Christine Perault-Pochat, Régis Bordet
Publikováno v:
Alternative and Complementary Therapies
Alternative and Complementary Therapies, Mary Ann Liebert, 2021, 76 (1), pp.53-54. ⟨10.1016/j.therap.2020.01.001⟩
Alternative and Complementary Therapies, Mary Ann Liebert, 2021, 76 (1), pp.53-54. ⟨10.1016/j.therap.2020.01.001⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69df64e3bf9184d0292b44099c14f729
https://hal.archives-ouvertes.fr/hal-03141733
https://hal.archives-ouvertes.fr/hal-03141733
Autor:
Danièle, Debruyne, Emilie, Monzon, Justine, Perino, Françoise, Haramburu, Amélie, Daveluy, Aurélie, Lazès-Charmetant, Isabelle, Giraudon
Publikováno v:
Therapie. 76(3)
This paper aims to present the main information presented at the 9th Meeting about addictovigilance in 2016 by four healthcare professionals and addiction experts on the issue of new psychoactive substance use. A new psychoactive substance (NPS) is d
Autor:
Françoise Haramburu, Danièle Debruyne, Justine Perino, Isabelle Giraudon, Aurélie Lazès-Charmetant, Amélie Daveluy, Emilie Monzon
Publikováno v:
Thérapie
Thérapie, EDP Sciences, A paraître, ⟨10.1016/j.therap.2020.07.005⟩
Thérapie, EDP Sciences, A paraître, ⟨10.1016/j.therap.2020.07.005⟩
This paper aims to present the main information presented at the 9th Meeting about addictovigilance in 2016 by four healthcare professionals and addiction experts on the issue of new psychoactive substance use. A new psychoactive substance (NPS) is d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::594a81dc1bb9f51d951d1f4af93d81ab
http://hdl.handle.net/20.500.12278/25936
http://hdl.handle.net/20.500.12278/25936
Autor:
Reynald Le Boisselier, Michel Spadari, Danièle Debruyne, Marylène Guerlais, Anne Batisse, Marion Lepelley, Alexandra Boucher, Céline Eiden, Sylvie Deheul, Anne Roussin, Amélie Daveluy, Elisabeth Frauger, Valérie Gibaja
Publikováno v:
Thérapie
Thérapie, EDP Sciences-Depuis 2016, la revue Thérapie n’est plus publiée par EDP Sciences.> Therapies (Elsevier), 2016, 71 (6), pp.553-562. ⟨10.1016/j.therap.2016.05.005⟩
Thérapie, EDP Sciences-Depuis 2016, la revue Thérapie n’est plus publiée par EDP Sciences.> Therapies (Elsevier), 2016, 71 (6), pp.553-562. ⟨10.1016/j.therap.2016.05.005⟩
Methylenedioxymethamphetamine (MDMA), the active compound of ecstasy, has been used for several years, especially by young adults to benefit of psychostimulant properties. By raising the level of neuromodulators in the synapsis, MDMA can cause psychi
Autor:
Danièle Debruyne, Maxence Ficheux, Nicolas Bouvier, Rémy Morello, Renaud Verdon, Elsa Le Blanc, Magalie Loilier, Laure Peyro Saint Paul, Thierry Lobbedez, Vincent Cattoir
Publikováno v:
Peritoneal Dialysis International
Peritoneal Dialysis International, Multimed Inc.; 1999, 2018, 38 (6), pp.463-466. ⟨10.3747/pdi.2017.00256⟩
Peritoneal Dialysis International, Multimed Inc.; 1999, 2018, 38 (6), pp.463-466. ⟨10.3747/pdi.2017.00256⟩
The DaptoDP (NCT 2012-005699-33) study aimed to evaluate the pharmacokinetic parameters of daptomycin (DAP) in peritoneal dialysis-related peritonitis (PDRP) patients following intraperitoneal (IP) administration. The authors have already reported th
Publikováno v:
Therapies. 70:167-178
Resume Depuis 2005, 215 nouvelles drogues ont ete signalees dans l'Union europeenne. Ces produits de synthese, crees pour esquiver la legislation sur les stupefiants, sont des derives de medicaments ou drogues existants. Leur disponibilite est sans l
Publikováno v:
Clinical pharmacology and therapeutics. 101(2)
The recent emergence of a multitude of synthetic cannabinoids (SCs) has generated a wealth of new information, suggesting the usefulness of state-of-the-art on lato sensu cannabinoids. By modulating a plurality of neurotransmission pathways, the endo